ICICI Prudential Pharma Healthcare and Diagnostics (p.h.d) Fund Direct Plan Growth-Insured vs Tata India Pharma and Healthcare Fund Direct Plan IDCW Payout
NAV, returns and costs — not a recommendation.
 ICICI Prudential Pharma Healthcare and Diagnostics (p.h.d) Fund Direct Plan Growth-Insured |  Tata India Pharma and Healthcare Fund Direct Plan IDCW Payout | |
|---|---|---|
| NAV | ₹46.11 | ₹37.0578 |
| NAV date | 2026-09-30 | 2026-09-30 |
| 1 year | +9.79% | +5.90% |
| 3 year (p.a.) | +21.49% | +17.51% |
| 5 year (p.a.) | +15.66% | +13.41% |
| Expense ratio | 0.87% | 0.67% |
| Fund size | ₹6453.52 Cr | ₹1386.99 Cr |
| Risk | — | — |
| Category | Sectoral Pharma and Healthcare | Sectoral Pharma and Healthcare |
Past performance does not guarantee future returns. Mutual fund investments are subject to market risks.